GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity

Published:2016-09-02 Issue:10 Volume:5 Page:e1227897
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Magee Michael S.¹²,Kraft Crystal L.²,Abraham Tara S.²,Baybutt Trevor R.²,Marszalowicz Glen P.³,Li Peng⁴,Waldman Scott A.²,Snook Adam E.²

Affiliation:

1. Bluebird Bio, Seattle, Cambridge, MA, USA

2. Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA

3. School of Biomedical Engineering, Science & Health Systems, Drexel University, Philadelphia, PA, USA

4. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

Funder

NIH

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/2162402X.2016.1227897

Reference53 articles.

1. Cancer Immunotherapy

2. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

3. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective;Molecular Biotechnology;2024-03-08

2. Recent advances and progress in immunotherapy of solid cancers;Advances in Cancer Research;2024

3. Translational research of new developments in targeted therapy of colorectal cancer;Pathology - Research and Practice;2023-12

4. Immunotherapy and immunoevasion of colorectal cancer;Drug Discovery Today;2023-09

5. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer;Archivum Immunologiae et Therapiae Experimentalis;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3